All News about Astrazeneca Plc ADR![]() ![]() ![]() ![]()
FDA Approves AstraZeneca's Truqap/Faslodex Combo Therapy For Breast Cancer, Competes With Gilead's Drug
November 17, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
Price Over Earnings Overview: AstraZeneca
November 06, 2023
Via Benzinga
![]() ![]()
Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology
November 14, 2023
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
![]() ![]() ![]() ![]() ![]()
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
November 09, 2023
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Can Diabetes, Weight-Loss Drugs Get Even Better?
October 30, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|